Evaluation of Novel Therapeutic Agents Against Breast Cancer: An Innovative Randomized Phase II Trial Design.
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2016
At a glance
- Drugs Interleukin-12 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 15 Jul 2016 Status changed from discontinued to completed.
- 16 Oct 2013 Lead trial centre amended as reported by ClinicalTrials.gov.